When is it appropriate to stop? Developing an M&E strategy to guide triple drug stopping decisions for lymphatic filariasis

Researchers

Grant status

Completed

Grant start date

25/05/2018

Grant funding

  • 2018: $398,583 from The Task Force for Global Health

Updated:  23 January 2021 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers